ArticleEClinicalMedicine2023

Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000-2018.

Lindsay M Morton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.